Anastrozole vs Aripiprazole: Completely Different Medications
These are two entirely different medications with completely unrelated uses—anastrozole is a hormonal cancer medication (aromatase inhibitor) for breast cancer, while aripiprazole is an antipsychotic for schizophrenia and bipolar disorder. The similar-sounding names are purely coincidental and can lead to dangerous medication errors if confused.
Anastrozole
Drug Class & Mechanism:
- Non-steroidal aromatase inhibitor that blocks estrogen production 1
- Chemically: 1,3-Benzenediacetonitrile, molecular formula C₁₇H₁₉N₅ 1
Approved Indications:
- Breast cancer risk reduction in high-risk postmenopausal women 2
- Adjuvant treatment of hormone receptor-positive early breast cancer 3
- Treatment of advanced breast cancer 4
Dosing:
- 1 mg orally once daily for 5 years 2
Key Clinical Considerations:
- Only for postmenopausal women—should never be prescribed to premenopausal women for breast cancer risk reduction 2
- Requires baseline bone density assessment before initiation due to increased bone loss risk 2
- Use with caution in patients with moderate bone mineral density loss; consider bisphosphonates or RANKL inhibitors 2
- Contraindicated in severe osteoporosis (T-score < -4 or >2 vertebral fractures) 2
Common Side Effects:
- Joint stiffness and arthralgias
- Vasomotor symptoms (hot flashes)
- Hypertension
- Dry eyes and vaginal dryness 2
- Increased fracture risk 2
Aripiprazole
Drug Class & Mechanism:
- Third-generation atypical antipsychotic with unique partial dopamine D₂ agonist activity 5, 6, 7
- Also partial agonist at serotonin 5-HT₁A receptors and antagonist at 5-HT₂A receptors 6, 8
- Chemically: 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone, molecular formula C₂₃H₂₇Cl₂N₃O₂ 5
Approved Indications:
- Schizophrenia and schizoaffective disorder 6, 7
- Acute bipolar mania 6
- Available as oral tablets (2-30 mg) and long-acting injectable formulations 5, 7
Dosing:
- Varies by indication; typically 10-30 mg orally once daily for schizophrenia 8
- Long-acting injectable options available with dosing intervals up to every 8 weeks 7
Key Clinical Considerations:
- Generally well-tolerated with low rates of metabolic side effects compared to other antipsychotics 7, 8
- Uniquely associated with reduced serum prolactin levels (unlike most antipsychotics) 7
- Low propensity for weight gain, cardiovascular abnormalities, or glucose dysregulation 8
Common Side Effects:
- Akathisia and tremor (10-11% incidence) 7
- Extrapyramidal symptoms (though lower than many alternatives) 8
- Motoric activation 6
Critical Safety Alert
These medications should never be substituted for one another. The similar names create a high risk for:
- Prescribing errors
- Dispensing errors
- Patient confusion
Always use both generic and brand names when prescribing, verify the indication matches the medication, and counsel patients on the specific purpose of their medication to prevent mix-ups.